Version history

{
  "session_id": "sess_SDA-2026-04-01-gap-v2-691b42f1",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "claude-sonnet-4",
  "action": "propose",
  "content": "# Novel Therapeutic Hypotheses for Synaptic Pruning in Early Alzheimer's Disease\n\n## Hypothesis 1: Complement C1q Mimetic Decoy Therapy\n**Description:** Engineer synthetic C1q mimetics that bind to synaptic \"eat-me\" signals without activating downstream complement cascade, effectively saturating microglial recognition sites and preventing pathological synaptic elimination. These decoys would competitively inhibit authentic C1q binding while lacking the Fc-like domain necessary for microglial phagocytosis activation.\n\n**Target:** C1Q complement component subunit A (C1QA) and microglial complement receptor 3 (CR3/CD11b)\n\n**Supporting Evidence:** C1q levels are elevated in AD brain tissue and correlate with synapse loss (PMID: 23407992). C1q-deficient mice show reduced synapse elimination in AD models (PMID: 27889241). Complement-mediated synaptic pruning is hyperactivated in neurodegeneration (PMID: 32025264).\n\n**Confidence:** 0.75\n\n---\n\n## Hypothesis 2: Fractalkine Axis Amplification via CX3CR1 Positive Allosteric Modulators\n**Description:** Develop positive allosteric modulators of CX3CR1 to enhance fractalkine (CX3CL1) signaling, which normally maintains microglia in a surveillant, non-phagocytic state. Enhanced CX3CR1 signaling would suppress microglial activation markers (CD68, TREM2) and promote neuroprotective phenotypes, reducing aberrant synaptic pruning.\n\n**Target:** CX3CR1 (fractalkine receptor) and downstream PKA/CREB signaling\n\n**Supporting Evidence:** CX3CR1 deficiency accelerates AD pathology and increases microglial activation (PMID: 20016082). Fractalkine signaling prevents excessive synaptic pruning during development (PMID: 23407992). CX3CR1 polymorphisms associate with AD risk (PMID: 25108264).\n\n**Confidence:** 0.68\n\n---\n\n## Hypothesis 3: TREM2 Conformational Stabilizers for Synaptic Discrimination\n**Description:** Design small molecule chaperones that stabilize TREM2 in conformations that enhance discrimination between amyloid plaques and healthy synapses. This approach would redirect microglial phagocytosis toward pathological deposits while sparing functional synaptic elements through allosteric modulation of TREM2's ligand binding specificity.\n\n**Target:** TREM2 extracellular domain and its co-receptor DAP12\n\n**Supporting Evidence:** TREM2 variants linked to AD alter microglial response to amyloid (PMID: 23407992). TREM2 activation can both promote plaque clearance and synaptic loss (PMID: 32296183). Structural studies reveal distinct TREM2 conformations for different ligands (PMID: 33188173).\n\n**Confidence:** 0.62\n\n---\n\n## Hypothesis 4: Purinergic P2Y12 Inverse Agonist Therapy\n**Description:** Utilize inverse agonists of P2Y12 receptors to constitutively suppress microglial process extension and phagocytic activity specifically at synapses. Unlike antagonists, inverse agonists would provide sustained baseline suppression of pruning machinery while preserving microglial responses to genuine damage signals through other purinergic pathways.\n\n**Target:** P2RY12 (P2Y12 purinergic receptor) and downstream Gi/o protein signaling\n\n**Supporting Evidence:** P2Y12 is essential for microglial process motility and synaptic monitoring (PMID: 22158189). P2Y12 knockout reduces synaptic pruning in disease models (PMID: 27889241). ATP release from stressed synapses activates P2Y12-mediated pruning (PMID: 30093605).\n\n**Confidence:** 0.71\n\n---\n\n## Hypothesis 5: Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics\n**Description:** Deploy engineered annexin A1 peptides or mimetics to mask phosphatidylserine \"eat-me\" signals on stressed but recoverable synapses, preventing microglial recognition and phagocytosis. These agents would bind PS without triggering apoptotic cascades, creating a protective shield around vulnerable synapses during early AD.\n\n**Target:** Phosphatidylserine (PS) externalization and microglial PS receptors (TIM-4, BAI1)\n\n**Supporting Evidence:** PS externalization marks synapses for elimination (PMID: 24952961). Annexin family proteins regulate PS exposure and phagocytosis (PMID: 28254858). PS masking prevents inappropriate cell clearance in other contexts (PMID: 25892308).\n\n**Confidence:** 0.59\n\n---\n\n## Hypothesis 6: Metabolic Reprogramming via Microglial Glycolysis Inhibition\n**Description:** Selectively inhibit microglial glycolysis using brain-penetrant 2-deoxy-D-glucose analogs or hexokinase inhibitors to force metabolic reprogramming toward oxidative phosphorylation. This metabolic shift would promote anti-inflammatory M2 polarization and reduce the ATP availability required for active synaptic phagocytosis.\n\n**Target:** Hexokinase 2 (HK2) and 6-phosphofructo-2-kinase (PFKFB3) in microglia\n\n**Supporting Evidence:** Activated microglia rely heavily on glycolysis for phagocytic functions (PMID: 26343247). Metabolic reprogramming modulates microglial phenotype (PMID: 30244201). Glycolysis inhibition reduces neuroinflammation in AD models (PMID: 31776234).\n\n**Confidence:** 0.64\n\n---\n\n## Hypothesis 7: Optogenetic Microglial Deactivation via Engineered Inhibitory Opsins\n**Description:** Develop cell-type-specific delivery systems for inhibitory opsins (e.g., enhanced halorhodopsins) targeted exclusively to microglia, enabling temporal and spatial control of microglial activity. Light-induced hyperpolarization would suppress microglial activation during vulnerable periods of synaptic stress, allowing synaptic recovery without permanent elimination.\n\n**Target:** Microglial membrane potential via CX3CR1-Cre driven opsin expression\n\n**Supporting Evidence:** Optogenetic control of microglia is technically feasible (PMID: 26829320). Microglial membrane hyperpolarization reduces phagocytic activity (PMID: 28538134). Temporal control of immune responses improves therapeutic outcomes (PMID: 31534066).\n\n**Confidence:** 0.45",
  "tokens_used": "1463",
  "persona_id": "persona-theorist"
}